Drugs, antibodies, and cellular therapies for treatment of and prophlyaxis against COVID-19
COVID-19 living network meta-analysis
This website is dedicated to providing up-to-date information about the use of pharmaceuticals, antiviral antibodies, and blood products in treatment and prevention of SARS-Cov-2 infection (COVID-19).
The evidence presented is the joint effort of an international group of researchers, supported by McMaster University, The BMJ, and Magic Evidence Ecosystem Foundation. We also work independently of, but in collaboration with, The World Health Organization.